No Data
No Data
Zhejiang Zhenyuan Share: Summary of Half-Year Report in 2024.
Zhejiang Zhenyuan Share: Half-year report for the year 2024.
Zhejiang Zhenyuan Share (000705.SZ): The Shangyu Bio-Synthesis project is progressing smoothly and is expected to begin trial production by the end of this year.
Zhejiang Zhenyuan Share (000705.SZ) stated on the investor interaction platform on July 19 that the Shangyu Biological Synthesis Project of the company is progressing smoothly and is expected to commence trial production by the end of this year.
Zhejiang Zhenyuan Share (000705.SZ) plans to acquire 10.89% equity from minority shareholders of Zhenyuan Chain.
Zhejiang Zhenyuan Share (000705.SZ) announced that the company plans to acquire... at a purchase price of 35.8172 million yuan...
Zhejiang Zhenyuan (000705.SZ) plans to pay 0.6 yuan for every 10 shares in 2023, excluding interest on June 7
Zhejiang Zhenyuan (000705.SZ) issued an announcement. The company's 2023 equity distribution plan is: to all shares...
Zhejiang Zhenyuan (000705.SZ): Zhenyuan Pharmaceutical plans to acquire 100% of the shares of two wholly-owned subsidiaries of Zhenyuan Chemical and Zhenyuan Supply Chain
Gelonghui, May 20 | Zhejiang Zhenyuan (000705.SZ) announced that the second interim meeting of the 11th board of directors of the company in 2024 reviewed and passed the “Proposal on the Wholly-owned Subsidiary Zhenyuan Pharmaceutical to Acquire 100% Shaoxing Zhenyuan Pharmaceutical Management Co., Ltd. (hereinafter referred to as “Zhenyuan Pharmaceutical”) and Zhejiang Zhenyuan Pharmaceutical Supply Chain, a wholly-owned subsidiary, agreed to acquire Shaoxing Zhenyuan Medical Device Chemical Reagent Co., Ltd. (hereinafter referred to as “Zhenyuan Pharmaceutical”) and Zhejiang Zhenyuan Pharmaceutical Supply Chain Chain Management Co., Ltd. (below
No Data